Cyclopentobarbital
![]() | |
Systematic (IUPAC) name | |
---|---|
5-(1-cyclopent-2-enyl)-5-prop-2-enyl-1,3- diazinane-2,4,6-trione | |
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number |
76-68-6 302-34-1 (sodium salt) |
ATC code | None |
PubChem | CID 6454 |
ChemSpider |
6212 ![]() |
Synonyms | Allylpental, Cyclopental, 5-Allyl-5-Δ2-Cyclopentenyl Barbituric Acid |
Chemical data | |
Formula | C12H14N2O3 |
Molar mass | 234.251 g/mol |
| |
| |
(verify) |
Cyclopentobarbital sodium (Cyclopal, Dormisan) is a barbiturate derivative invented in the 1940s.[1] It has sedative and anticonvulsant properties, and was used primarily as an anaesthetic in veterinary medicine.[2] Cyclopal is considered similar in effects to phenobarbital but lasts almost three times as long, and is considered a long-acting barbiturate with a fairly slow onset of action.
See also
References
- ↑ Martin, J. R.; Godel, T.; Hunkeler, W.; Jenck, F.; Moreau, J.-L.; Sleight, A. J.; Widmer, U. (2000). "Psychopharmacological Agents". doi:10.1002/0471238961.1619250313011820.a01.
- ↑ Vander Brook MJ, Cartland GF. A Pharmacologic Study of 5-Allyl-5-Cyclopentenyl Barbituric Acid (Cyclopal). Journal of Pharmacology And Experimental Therapeutics, 1944, 80(2): 119-125
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.